Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study

NCT07094776 is registered in ClinicalTrials.gov with Havva Betül Bacak as lead sponsor.

NCT NCT07094776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07094776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study
Lead sponsor
Havva Betül Bacak
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 18, 2025
Completion date
August 20, 2025
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance syndrome, polycystic ovary syndrome (pcos)